Targeting growth factor and cytokine pathways to treat idiopathic pulmonary fibrosis

H Ma, S Liu, S Li, Y Xia - Frontiers in Pharmacology, 2022 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown origin
that usually results in death from secondary respiratory failure within 2–5 years of diagnosis …

Mitogen-activated protein kinase phosphatases: No longer undruggable?

SR Shillingford, AM Bennett - Annual review of pharmacology …, 2023 - annualreviews.org
Phosphatases and kinases maintain an equilibrium of dephosphorylated and
phosphorylated proteins, respectively, that are required for critical cellular functions …

Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis

CY Perrot, T Karampitsakos… - American Journal of …, 2023 - journals.physiology.org
Pulmonary fibrosis results from a plethora of abnormal pathogenetic events. In idiopathic
pulmonary fibrosis (IPF), inhalational, environmental, or occupational exposures in …

Mesenchymal stem cell‐derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA‐29b‐3p in …

X Wan, S Chen, Y Fang, W Zuo, J Cui… - Journal of Cellular …, 2020 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease, usually leads to an
irreversible distortion of the pulmonary structure. The functional roles of bone marrow …

Pathophysiological roles of stress-activated protein kinases in pulmonary fibrosis

Y Kasuya, JD Kim, M Hatano, K Tatsumi… - International Journal of …, 2021 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is one of the most symptomatic progressive fibrotic lung
diseases, in which patients have an extremely poor prognosis. Therefore, understanding the …

Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic‐Dependent Mechanisms

J Bai, L Yin, WJ Yu, YL Zhang, QY Lin… - Oxidative Medicine and …, 2022 - Wiley Online Library
Cardiac lymphatic vessel growth (lymphangiogenesis) and integrity play an essential role in
maintaining tissue fluid balance. Inhibition of lymphatic lymphangiogenesis is involved in …

MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution

SM Fortier, NM Walker, LR Penke… - The Journal of …, 2024 - Am Soc Clin Investig
Fibrosis following tissue injury is distinguished from normal repair by the accumulation of
pathogenic and apoptosis-resistant myofibroblasts (MFs), which arise primarily by …

A pilot HRCT follow-up study to test the feasibility of predictive efficacy of serum periostin in idiopathic pulmonary fibrosis

M Liu, ZJ Cheng, J Chen, H Li, M Xue, X Fu… - Journal of …, 2024 - Taylor & Francis
Background While serum periostin and Krebs von den Lungen-6 (KL-6) have been
acknowledged as independent markers in idiopathic pulmonary fibrosis (IPF) diagnosis, the …

Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?

K Bączek, WJ Piotrowski - Frontiers in Pharmacology, 2024 - frontiersin.org
Sarcoidosis, an enigmatic disease with unknown etiology, is characterized by inflammation
and the potential involvement of various organs, predominantly the lungs and intrathoracic …

MAP kinase phosphatase-5 deficiency protects against pressure overload-induced cardiac fibrosis

C Zhong, K Min, Z Zhao, C Zhang, E Gao… - Frontiers in …, 2021 - frontiersin.org
Cardiac fibrosis, a pathological condition due to excessive extracellular matrix (ECM)
deposition in the myocardium, is associated with nearly all forms of heart disease. The …